Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis

Additional Metadata
Persistent URL	doi.org/10.1016/j.cgh.2016.12.034, hdl.handle.net/1765/99674
Journal	Clinical Gastroenterology and Hepatology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kroep, S., Heberle, C., Curtius, K., Kong, C. Y., Lansdorp-Vogelaar, I., Ali, A., Wolf, W. A., Shaheen, N. J., Spechler, S. J., Rubenstein, J., Nishioka, N. S., Meltzer, S. J., Hazelton, W., van Ballegooijen, M., Tramontano, A. C., Gazelle, S., Luebeck, E. G., Inadomi, J.& Hur, C. (2017). Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis. Clinical Gastroenterology and Hepatology.https://doi.org/10.1016/j.cgh.2016.12.034

Publication